Continuing operationsNote2017
£000
2016
£000
restated
Revenue490,727101,910
Cost of sales4(71,226)(72,329)
Gross profit19,50129,581
Administrative expenses5(7,565)(6,297)
Profit on sale of PPE9
Provision for doubtful debt17(1,106)
Gain on sale of subsidiary5,988
Gain on sale of joint venture6,965
Share of loss of associates14(238)(138)
Share of profit/(loss) of joint ventures1413(232)
Loss on investments(1)
Revaluation of investment properties121,46618,015
Operating profit26,12939,832
Finance cost – interest expense7(6,998)(6,576)
Finance income – interest receivable and similar income8458477
Profit before tax19,58933,733
Income tax9(3,810)(4,841)
Total profit and comprehensive income for the year15,77928,892
Attributable to:
– Shareholders of the Company15,77928,293
– Non-controlling interests599
Earnings per share for profit attributable to the equity holders of the Company
during the year
– basic107.82p14.01p
– diluted107.46p13.38p

The accompanying accounting policies and notes form part of these financial statements.